RxDoctor Payments Data

Kay Thompson

Adult Health · Washington, PANPI 1184694119

Payments from drug & device makers

$1,568in general payments, 2019–2025

Across 96 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$390
  • Pfizer$388
  • Lilly USA, LLC$155
  • AbbVie$132
  • Lundbeck LLC$84
  • Boehringer Ingelheim$70
  • plus $348 from 13 others

What the payments were for

  • Food & beverage$1,568100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,568 in reported general payments places this provider in the 75th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$4,442
Medicare patients
29
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban52$51,000
OzempicSemaglutide37$43,478
TrulicityDulaglutide19$27,221
JardianceEmpagliflozin28$17,578
VraylarCariprazine Hcl16$13,343
XareltoRivaroxaban11$10,963
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$9,159
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,971
Breo ElliptaFluticasone/Vilanterol14$5,151
Atorvastatin Calcium217$2,718
Pantoprazole Sodium95$2,603
CholestyramineCholestyramine (With Sugar)12$1,951
Rosuvastatin Calcium52$1,396
Losartan Potassium137$1,356
Gabapentin76$1,123

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$388$51,00052 claims
Novo NordiskOzempic$390$43,47837 claims
Lilly USA, LLCTrulicity$155$27,22119 claims
GSKAnoro Ellipta, Trelegy Ellipta, Breo Ellipta$48$21,28145 claims
Boehringer IngelheimJardiance$70$17,57828 claims
AbbVieVraylar$132$13,34316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 899 adult health providers in Pennsylvania.

Other adult health in Washington

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →